[A multicenter randomized prospective study of concurrent chemoradiation with 60 Gy versus 50 Gy for inoperable esophageal squamous cell carcinoma].

作者：Yuanji Xu, Weiguo Zhu, Zhongxing X. Liao, Yaozhong Kong, W W Wang, Jingyu Li, Rong Huang, Han He, Xinmei Yang, Lu Liu, Zewen Sun, Hang He, Yong Bao, Manwen Zeng, Juan Pu, Wenqi Hu, Jun Ma, Hao Jiang, Zhenyi Liu, Tingting Zhuang, Bangxian Tan, Xianghui Du, Gang-Hao Qiu, Xingchen Zhou, Yuan Ji, Xiao Hu, Jian Wang, H L, Xiao Zheng, Jin Huang, Ao Liu, XuChuan Liang, Hua Tao, Juying Zhou, Yihong Liu, M Chen · 发表于：PubMed · 年份：2020 · DOI：10.3760/cma.j.cn112137-20200303-00574 · 被引用次数：8 · 研究领域：Esophageal Cancer Research and Treatment、Lung Cancer Diagnosis and Treatment、Radiopharmaceutical Chemistry and Applications

The efficacy in disease control is similar between 60 Gy and 50 Gy using modern radiation technology concurrent with chemotherapy for ESCC. The 50 Gy should be recommended as the regular radiation dose with CCRT for ESCC.